ProMIS Neurosciences Inc. PMN

NAS: PMN | ISIN: CA74346M1095   1/05/2025
0,650 USD (+4,86%)
(+4,86%)   1/05/2025

18 april 2022 · Argus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF) · Persbericht

17 november 2021 · A Second Independent Proxy Advisor, ISS, Recommends Promis Neurosciences Shareholders Vote for the Share Consolidation · Persbericht

12 november 2021 · ProMIS Neurosciences Announces Third Quarter 2021 Results · Persbericht

2 november 2021 · Glass Lewis Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation at the Upcoming Special Meeting · Persbericht

22 oktober 2021 · ProMIS Neurosciences Appoints Accomplished Biotech Executive, Dr. Maggie Shafmaster, to its Board of Directors · Persbericht

22 oktober 2021 · ProMIS Neurosciences Announces Update to Senior Management Team · Persbericht

21 oktober 2021 · ProMIS Neurosciences Files Special Meeting Proxy Material · Persbericht

7 oktober 2021 · ProMIS Neurosciences Announces Special Shareholder Meeting · Persbericht

15 september 2021 · ProMIS Neurosciences to Present at the Second Annual Undruggable Leaders Forum, September 15-16, 2021 · Persbericht

13 september 2021 · ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 23rd Annual Investment Conference · Persbericht

1 september 2021 · ProMIS Neurosciences appoints accomplished biotechnology executive, Josh Mandel-Brehm, to its Board of Directors · Persbericht

25 augustus 2021 · ProMIS Neurosciences Closes Upsized US$20,125,000 Public Offering · Persbericht

18 augustus 2021 · ProMIS Neurosciences Inc. Announces Upsize of Previously Announced Public Offering of Units to US$17.5M · Persbericht

18 augustus 2021 · ProMIS Neurosciences Inc. Announces Pricing of US$15 Million Public Offering of Units · Persbericht

17 augustus 2021 · ProMIS Neurosciences Inc. Announces US$15 Million Offering of Units · Persbericht

12 augustus 2021 · ProMIS Neurosciences Announces Second Quarter 2021 Results · Persbericht

4 augustus 2021 · ProMIS Neurosciences Issues Chairman’s Memorandum · Persbericht

22 juli 2021 · ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference · Persbericht

8 juli 2021 · ProMIS Neurosciences Obtains Receipt for Final Base Shelf Prospectus · Persbericht

2 juli 2021 · ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders · Persbericht

Mijn selecties